GlucanBio
St Louis, Missouri, United States · Founded 2012
About GlucanBio
GlucanBio technology developed from the University of Wisconsin and Center for Biorenewable Chemicals (CBiRC) at Iowa State. Our primary purpose is to produce furan derivatives from biomass with cost and performance advantages. The market opportunity is strong and relevant, not only for furfural, but also for HMF, DMF, THF and FDCA.Our team offers best-in-field expertise in catalysis, IP management, engineering scale-up, and early stage commercialization.Engaging great minds like Jim Dumesic, a world-renowned catalytic chemist, and Brent Shanks, a highly acclaimed principal in the industry, gives us an advantage in hurdling technical roadblocks.
Company Facts
- Founded: 2012
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.2M
- Funding stage: Seed
- Last round: Seed (Feb 2017)
- Website: http://glucanbio.com/
- Phone: [email protected]
Industries & Categories
Biotechnology, Chemical, Renewable Energy
Canonical: https://fsome.com/organization/glucanbio-2252641 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.